The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2017 Update
Abstract
This report describes the outcomes of a process undertaken to review and update the National Safety Council's Alcohol, Drugs and Impairment Division's recommendations for the toxicological investigation of suspected alcohol and drug-impaired driving cases and motor vehicle fatalities. The updates to the recommendations are made based on a survey of practices in laboratories in the USA and Canada performing testing in these cases, consideration of existing epidemiological crash and arrest data, current drug use patterns, and practical considerations of widely available technology platforms in laboratories performing this work. The final recommendations updates are derived from a consensus meeting of experts recruited from survey respondents and the membership of the National Safety Council's Alcohol, Drug and Impairment Division. The principal changes in this round of recommendations include removal of butalbital, phenobarbital, and phencyclidine from Tier I (mandatory) to Tier II (optional) due to changes in prevalence. In addition, buprenorphine, fentanyl, tramadol, and their metabolites were moved from Tier II to Tier I due to increased prevalence and concerns about their potential for causing impairment. In addition, screening and confirmatory cutoffs for the oral fluid scope were further refined. Other additions were made to the list of Tier II compounds including fentanyl analogs (e.g., acetylfentanyl, butyrylfentanyl, furanylfentanyl, etc), mitragynine, novel opioids (e.g., MT-45, U-47700), atypical antipsychotics, and novel benzodiazepines (e.g., clonazolam, flubromazolam, etc).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the rise in HRMS use in screening from 2017 to 2021 demonstrates the shift toward broad, mass spectral-based screening methods.”
From Evaluation of enzyme-linked immunosorbent assay screening kits for the detection of nitazene analogs (2025) · cites this paper as [19]
Citations
Cites
Strengthening Forensic Science in the United States: A Path Forward
Council, N. R. (2009) · CrimRxiv · doi:10.21428/cb6ab371.b2d683d2 · Cited by 1,461
Strengthening forensic science in the United States : a path forward
Policy, L. (2009) · National Academies Press eBooks · Cited by 964
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review
Logan, B. K., Mohr, A. L. A., Friscia, M., Krotulski, A. J., Papsun, D. M., Kacinko, S. L., Ropero-Miller, J. D., & Huestis, M. A. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx031 · Cited by 166 · cited 1×
“These include compounds such as the synthetic cannabinoids, cathinones and “bath salts”, and novel opioids, especially analogs (4, 5).”
BackgroundSelf-citationNon-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results
Cone, E. J., Bigelow, G. E., Herrmann, E. S., Mitchell, J. M., LoDico, C., Flegel, R. R., & Vandrey, R. G. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku116 · Cited by 85 · cited 1×
“There was some discussion about the possibility of raising the urine screening and confirmation thresholds to concentrations that would rule out the possibility of passive exposure (6).”
BackgroundMoore, C. M., Rana, S., & Coulter, C. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.12.008 · Cited by 66 · cited 1×
“Tramadol and its metabolite O-desmethyltramadol were added with recommended screening and confirmation cutoffs for tramadol of 50 and 10 ng/mL respectively in oral fluid (7).”
BackgroundRecommendations for Toxicological Investigation of Drug Impaired Driving*
Farrell, L. J., Kerrigan, S., & Logan, B. K. (2007) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2007.00516.x · Cited by 62 · cited 1×
“Based on the results of the survey and consensus input from a subsequent face-to-face meeting of a panel of forensic toxicologists, the first recommendations document was published in 2007, and represents a list of drugs which ought to be tested for in suspected impaired driving cases (1).”
BackgroundSelf-citationLogan, B. K., Lowrie, K. J., Turri, J. L., Yeakel, J. K., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., & Farrell, L. J. (2013) · Journal of Analytical Toxicology · doi:10.1093/jat/bkt059 · Cited by 53 · cited 2×
“The 2013 recommendations listed 50 Tier II compounds that may be emerging, or have regional but not national prevalence in DUID populations (3).”
BackgroundMethodSelf-citationDavies, B., Bayard, C., Larson, S. J., Zarwell, L. W., & Mitchell, R. A. (2015) · Journal of Analytical Toxicology · doi:10.1093/jat/bkv136 · Cited by 22 · cited 1×
“These include compounds such as the synthetic cannabinoids, cathinones and “bath salts”, and novel opioids, especially analogs (4, 5).”
Background
Cited by
Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes
Busardò, F. P., & Jones, A. W. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1519194 · Cited by 86
“However, obtaining samples of saliva is less invasive than drawing blood, which makes this fluid more convenient for off-site testing, such as drug screening in various populations, such as motorists [83,84].”
BackgroundAlsenedi, K. A., & Morrison, C. (2018) · Analytical Methods · doi:10.1039/c8ay00041g · Cited by 75
The Role of Mass Spectrometry in the Cannabis Industry
Nie, B., Henion, J. D., & Ryona, I. (2019) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-019-02164-z · Cited by 65
“The topic of driving under the influence of drugs (DUID) raises increasing concerns by authorities such as the National Safety Council’s Alcohol, Drugs and Impairment Division (NSC-ADID) [38] and theNational HighwayTransportation Safety Administration (NHTSA) [39] as well as the general public.”
BackgroundD’Orazio, A. L., Mohr, A. L. A., Chan-Hosokawa, A., Harper, C., Huestis, M. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., et al. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab064 · Cited by 60
“The updated recommendations were published in 2018 (6).”
BackgroundSelf-citationAzofeifa, A., Rexach-Guzmán, B. D., Hagemeyer, A. N., Rudd, R. A., & Sauber‐Schatz, E. K. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6850a1 · Cited by 57
“In addition, adoption and application of standards for toxicology testing and support for laboratories to implement recommendations are needed to improve understanding of the prevalence of drug- and polysubstance-impaired driving (10).”
Background
Metadata
- Authors
- Logan, B. K., D’Orazio, A. L., Mohr, A. L. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., Scott, K. S., & Huestis, M. A.
- Affiliations
- Fredric Rieders Family Foundation (US)
- New York City Police Department (US)
- Wisconsin State Laboratory of Hygiene, 2601 Agriculture Drive, PO Box 7996, Madison, WI 53707-7996, USA
- New Hampshire Department of Safety, Division of State Police Forensic Laboratory, 33 Hazen Drive, Concord, NH 03305, USA
- Sam Houston State University (US)
- Arcadia University (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Logan, Barry K
- ORCID
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-23
- Volume
- 42
- Issue
- 2
- Pages
- 63-68
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W2770985891
- Semantic Scholar
- 42f69c765005e038ac02e0159690f125474c550d
- Cited by
- 78
- References
- 8
- Citations by year
- 2025: 8 · 2024: 6 · 2023: 7 · 2022: 12 · 2021: 8 · 2020: 15 · 2019: 11 · 2018: 10 · 2017: 1
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Analytical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Justice
- Washington State University
- Rhode Island Department of Health
- National Science Council
- College of Engineering, Michigan State University
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Traffic and Road Safety
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- drug-impaired driving, traffic fatalities, toxicological investigation, forensic toxicology, oral fluid testing, fentanyl, buprenorphine, tramadol, fentanyl analogs, butalbital, phenobarbital, phencyclidine, mitragynine, atypical antipsychotics, expert consensus recommendations
- MeSH terms
- Accidents, Traffic, Driving Under the Influence, Canada, Humans, Illicit Drugs, Substance Abuse Detection, Guidelines as Topic, Forensic Toxicology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2017 Update. https://app.cochat.ai/papers/10.1093/jat/bkx082
- The paper
- Logan, B. K., D’Orazio, A. L., Mohr, A. L. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., Scott, K. S., & Huestis, M. A. (2018). Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2017 Update. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkx082
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.